Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.

Jung HS, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK, Her SW, Ju W, Choi YL, Song SY, Kim JK, Kim YD, Shim GY, Shin YK.

Int J Cancer. 2012 Apr 15;130(8):1925-36. doi: 10.1002/ijc.26197. Epub 2011 Aug 8.

2.

Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.

Zhou J, Peng C, Li B, Wang F, Zhou C, Hong D, Ye F, Cheng X, Lü W, Xie X.

Gynecol Oncol. 2012 Feb;124(2):296-302. doi: 10.1016/j.ygyno.2011.10.028. Epub 2011 Nov 3.

PMID:
22056554
3.

Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.

Gu W, Putral L, Hengst K, Minto K, Saunders NA, Leggatt G, McMillan NA.

Cancer Gene Ther. 2006 Nov;13(11):1023-32. Epub 2006 Jun 30.

PMID:
16810314
4.

Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma.

Liu WL, Green N, Seymour LW, Stevenson M.

Cancer Gene Ther. 2009 Oct;16(10):764-75. doi: 10.1038/cgt.2009.24. Epub 2009 Apr 10.

PMID:
19363466
5.

Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.

Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, Tsukazaki K, Aoki D.

Int J Oncol. 2006 Sep;29(3):541-8.

PMID:
16865269
6.

Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.

Jung HS, Rajasekaran N, Song SY, Kim YD, Hong S, Choi HJ, Kim YS, Choi JS, Choi YL, Shin YK.

Int J Mol Sci. 2015 May 29;16(6):12243-60. doi: 10.3390/ijms160612243.

7.

Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.

Zhou J, Li B, Peng C, Wang F, Fu Z, Zhou C, Hong D, Ye F, Lü W, Xie X.

Antiviral Res. 2013 May;98(2):305-13. doi: 10.1016/j.antiviral.2013.03.010. Epub 2013 Mar 21.

PMID:
23523766
8.

Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo.

Niu XY, Peng ZL, Duan WQ, Wang H, Wang P.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):743-51.

PMID:
16681755
9.

Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.

Kennedy EM, Kornepati AV, Goldstein M, Bogerd HP, Poling BC, Whisnant AW, Kastan MB, Cullen BR.

J Virol. 2014 Oct;88(20):11965-72. doi: 10.1128/JVI.01879-14. Epub 2014 Aug 6.

10.

Effect of simultaneous silencing of HPV-18 E6 and E7 on inducing apoptosis in HeLa cells.

Qi Z, Xu X, Zhang B, Li Y, Liu J, Chen S, Chen G, Huo X.

Biochem Cell Biol. 2010 Aug;88(4):697-704. doi: 10.1139/O10-005.

PMID:
20651842
11.

RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.

Putral LN, Bywater MJ, Gu W, Saunders NA, Gabrielli BG, Leggatt GR, McMillan NA.

Mol Pharmacol. 2005 Nov;68(5):1311-9. Epub 2005 Aug 24.

12.

TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.

Hu Z, Ding W, Zhu D, Yu L, Jiang X, Wang X, Zhang C, Wang L, Ji T, Liu D, He D, Xia X, Zhu T, Wei J, Wu P, Wang C, Xi L, Gao Q, Chen G, Liu R, Li K, Li S, Wang S, Zhou J, Ma D, Wang H.

J Clin Invest. 2015 Jan;125(1):425-36. doi: 10.1172/JCI78206. Epub 2014 Dec 15.

13.

Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.

Munagala R, Aqil F, Jeyabalan J, Gupta RC.

Cancer Lett. 2015 Jan 28;356(2 Pt B):536-46. doi: 10.1016/j.canlet.2014.09.037. Epub 2014 Oct 7.

PMID:
25304375
14.

Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells.

Hong D, Lu W, Ye F, Hu Y, Xie X.

Br J Cancer. 2009 Nov 17;101(10):1798-804. doi: 10.1038/sj.bjc.6605344. Epub 2009 Oct 13.

15.

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers.

Chang JT, Kuo TF, Chen YJ, Chiu CC, Lu YC, Li HF, Shen CR, Cheng AJ.

Cancer Gene Ther. 2010 Dec;17(12):827-36. doi: 10.1038/cgt.2010.38. Epub 2010 Oct 1.

16.

Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.

Kim YW, Chaturvedi PK, Chun SN, Lee YG, Ahn WS.

Oncol Rep. 2015 Apr;33(4):1675-82. doi: 10.3892/or.2015.3760. Epub 2015 Jan 28.

PMID:
25633640
17.

Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.

Yamato K, Fen J, Kobuchi H, Nasu Y, Yamada T, Nishihara T, Ikeda Y, Kizaki M, Yoshinouchi M.

Cancer Gene Ther. 2006 Mar;13(3):234-41.

PMID:
16138119
18.

Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.

Jonson AL, Rogers LM, Ramakrishnan S, Downs LS Jr.

Gynecol Oncol. 2008 Nov;111(2):356-64. doi: 10.1016/j.ygyno.2008.06.033. Epub 2008 Aug 27.

PMID:
18755502
19.

HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.

Hu D, Zhou J, Wang F, Shi H, Li Y, Li B.

Arch Gynecol Obstet. 2015 Dec;292(6):1345-54. doi: 10.1007/s00404-015-3787-x. Epub 2015 Jun 21.

PMID:
26093522
20.

RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.

Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.

Apoptosis. 2008 Feb;13(2):273-81.

PMID:
18060502
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk